Copyright Reports & Markets. All rights reserved.

Global Psoriatic Arthritis Drug Market Size, Status and Forecast 2019-2025

Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Psoriatic Arthritis Drug Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 TNF Inhibitors
      • 1.4.3 PDE4 Inhibitors
      • 1.4.4 Interleukin Blockers
      • 1.4.5 Other
    • 1.5 Market by Application
      • 1.5.1 Global Psoriatic Arthritis Drug Market Share by Application (2014-2025)
      • 1.5.2 Mild Psoriatic Arthritis
      • 1.5.3 Moderate Psoriatic Arthritis
      • 1.5.4 Severe Psoriatic Arthritis
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Psoriatic Arthritis Drug Market Size
    • 2.2 Psoriatic Arthritis Drug Growth Trends by Regions
      • 2.2.1 Psoriatic Arthritis Drug Market Size by Regions (2014-2025)
      • 2.2.2 Psoriatic Arthritis Drug Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Psoriatic Arthritis Drug Market Size by Manufacturers
      • 3.1.1 Global Psoriatic Arthritis Drug Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Psoriatic Arthritis Drug Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Psoriatic Arthritis Drug Market Concentration Ratio (CR5 and HHI)
    • 3.2 Psoriatic Arthritis Drug Key Players Head office and Area Served
    • 3.3 Key Players Psoriatic Arthritis Drug Product/Solution/Service
    • 3.4 Date of Enter into Psoriatic Arthritis Drug Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Psoriatic Arthritis Drug Market Size by Type (2014-2019)
    • 4.2 Global Psoriatic Arthritis Drug Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Psoriatic Arthritis Drug Market Size (2014-2019)
    • 5.2 Psoriatic Arthritis Drug Key Players in United States
    • 5.3 United States Psoriatic Arthritis Drug Market Size by Type
    • 5.4 United States Psoriatic Arthritis Drug Market Size by Application

    6 Europe

    • 6.1 Europe Psoriatic Arthritis Drug Market Size (2014-2019)
    • 6.2 Psoriatic Arthritis Drug Key Players in Europe
    • 6.3 Europe Psoriatic Arthritis Drug Market Size by Type
    • 6.4 Europe Psoriatic Arthritis Drug Market Size by Application

    7 China

    • 7.1 China Psoriatic Arthritis Drug Market Size (2014-2019)
    • 7.2 Psoriatic Arthritis Drug Key Players in China
    • 7.3 China Psoriatic Arthritis Drug Market Size by Type
    • 7.4 China Psoriatic Arthritis Drug Market Size by Application

    8 Japan

    • 8.1 Japan Psoriatic Arthritis Drug Market Size (2014-2019)
    • 8.2 Psoriatic Arthritis Drug Key Players in Japan
    • 8.3 Japan Psoriatic Arthritis Drug Market Size by Type
    • 8.4 Japan Psoriatic Arthritis Drug Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Psoriatic Arthritis Drug Market Size (2014-2019)
    • 9.2 Psoriatic Arthritis Drug Key Players in Southeast Asia
    • 9.3 Southeast Asia Psoriatic Arthritis Drug Market Size by Type
    • 9.4 Southeast Asia Psoriatic Arthritis Drug Market Size by Application

    10 India

    • 10.1 India Psoriatic Arthritis Drug Market Size (2014-2019)
    • 10.2 Psoriatic Arthritis Drug Key Players in India
    • 10.3 India Psoriatic Arthritis Drug Market Size by Type
    • 10.4 India Psoriatic Arthritis Drug Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Psoriatic Arthritis Drug Market Size (2014-2019)
    • 11.2 Psoriatic Arthritis Drug Key Players in Central & South America
    • 11.3 Central & South America Psoriatic Arthritis Drug Market Size by Type
    • 11.4 Central & South America Psoriatic Arthritis Drug Market Size by Application

    12 International Players Profiles

    • 12.1 Abbvie
      • 12.1.1 Abbvie Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Psoriatic Arthritis Drug Introduction
      • 12.1.4 Abbvie Revenue in Psoriatic Arthritis Drug Business (2014-2019)
      • 12.1.5 Abbvie Recent Development
    • 12.2 Janssen
      • 12.2.1 Janssen Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Psoriatic Arthritis Drug Introduction
      • 12.2.4 Janssen Revenue in Psoriatic Arthritis Drug Business (2014-2019)
      • 12.2.5 Janssen Recent Development
    • 12.3 Amgen
      • 12.3.1 Amgen Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Psoriatic Arthritis Drug Introduction
      • 12.3.4 Amgen Revenue in Psoriatic Arthritis Drug Business (2014-2019)
      • 12.3.5 Amgen Recent Development
    • 12.4 Pfizer
      • 12.4.1 Pfizer Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Psoriatic Arthritis Drug Introduction
      • 12.4.4 Pfizer Revenue in Psoriatic Arthritis Drug Business (2014-2019)
      • 12.4.5 Pfizer Recent Development
    • 12.5 Eli-lilly
      • 12.5.1 Eli-lilly Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Psoriatic Arthritis Drug Introduction
      • 12.5.4 Eli-lilly Revenue in Psoriatic Arthritis Drug Business (2014-2019)
      • 12.5.5 Eli-lilly Recent Development
    • 12.6 Celgene
      • 12.6.1 Celgene Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Psoriatic Arthritis Drug Introduction
      • 12.6.4 Celgene Revenue in Psoriatic Arthritis Drug Business (2014-2019)
      • 12.6.5 Celgene Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In 2018, the global Psoriatic Arthritis Drug market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

      This report focuses on the global Psoriatic Arthritis Drug status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Psoriatic Arthritis Drug development in United States, Europe and China.

      The key players covered in this study
      Abbvie
      Janssen
      Amgen
      Pfizer
      Eli-lilly
      Celgene
      ...

      Market segment by Type, the product can be split into
      TNF Inhibitors
      PDE4 Inhibitors
      Interleukin Blockers
      Other

      Market segment by Application, split into
      Mild Psoriatic Arthritis
      Moderate Psoriatic Arthritis
      Severe Psoriatic Arthritis

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Psoriatic Arthritis Drug status, future forecast, growth opportunity, key market and key players.
      To present the Psoriatic Arthritis Drug development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Psoriatic Arthritis Drug are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now